Reducing Lung Cancer-Related Anxiety (RELAX)

Stopped early · Not applicable

Conditions studied: Lung Cancer

In brief

The purpose of this research study is to compare the effects of music and different levels of device-guided breathing on anxiety and shortness of breath in lung cancer survivors.

Key facts

Study ID

NCT02063828

Run by

Wake Forest University Health Sciences

People needed

46

Starts

2015-07-30

Expected to finish

2019-12-23

Last updated by the study team

2021-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Past History of any lung cancer
• For Stage I-III disease, patients should be 2-24 months post-completion of surgery, radiation therapy and/or chemotherapy with no further planned treatment during the 12-week study and no evidence of disease.
• For Stage IV disease, patients may be receiving no treatment or may be receiving maintenance treatment with a target agent, chemotherapy, or immunotherapy provided the most recent imaging does not demonstrate progressive disease.
• After completion of all three screening questionnaires, participant must score accordingly on at least one questionnaire to be eligible.
• Willing/able to attend brief introductory session and use assigned device for the assigned period of time (15 minutes once or twice per day), at least 5 days per week for 12 weeks
• Age ≥ 18 years
• Must have telephone

You may not qualify if…

• Patient does not understand English
• Active lung infection
• Progressive cancer (must be considered no evidence of disease or stable)
• Any change in psychotropic medications in past 30 days
• Hearing loss that would preclude participating in interventions. Adequate hearing to participate will be determined via: (1) Response of "no" to the question ["Do you have a hearing problem now?"] Participants with hearing aids will be allowed to enroll as long as their hearing is adequate to hear the sounds on the study devices. If necessary, potential study participants will receive a brief test trial with the RESPeRATE device. If they indicate inability to hear the guiding tones, they will not be enrolled in the study.
• Cortisol Exclusion
• Participants with endocrine disorders (e.g., diabetes and thyroid disorders) or on steroid-based medications are excluded from the cortisol portion of the study (with the exception of topical hydrocortisone that is permitted).

Where it is running

• Beebe Health Campus — Rehoboth Beach, Delaware, United States
• Cancer Center of Kansas-Wichita Medical Arts Tower — Wichita, Kansas, United States
• Cancer Center of Kansas - Wichita — Wichita, Kansas, United States
• Mercy Hospital — Coon Rapids, Minnesota, United States
• Fairview Southdale Hospital — Edina, Minnesota, United States
• Saint John's Hospital - Healtheast — Maplewood, Minnesota, United States
• Abbott-Northwestern Hospital — Minneapolis, Minnesota, United States
• Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina, United States
• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States
• Prisma Health Greenville Memorial Hospital — Greenville, South Carolina, United States
• Spartanburg Medical Center — Spartanburg, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.